Meningitis outbreak spotlights risks of drug mixing
Two people blinded in Washington, D.C., in 2005. Three dead in Virginia in 2006 and three more in Oregon the following year. Twenty-one dead polo horses in Florida in 2009. Earlier this year, 33 people in seven states with fungal eye infections.
And now, at least five people dead and 35 sickened with fungal meningitis that has been linked to steroid shots for back pain.
Deadly meningitis outbreak in U.S.
All these disasters involved medicines that had been custom-mixed at what are called "compounding pharmacies" - laboratories that supply hospitals, clinics and doctors to a much wider degree in the U.S. than many people realize.
These pharmacies mix solutions, creams and other medicines used to treat everything from menopause symptoms and back pain to vision loss and cancer. Unlike manufactured drugs, these products are not subject to approval by the Food and Drug Administration. And some have turned out to be dangerously contaminated.
- Meningitis scare has patients on edge
- Meningitis outbreak may affect more than 23 states
- Watch: Woman may have been exposed to meningitis
Compounding pharmacies often obtain drugs from manufacturers and then split them into smaller doses, or mix ingredients sold in bulk. Any of those steps can easily lead to contamination if sterile conditions aren't maintained. For example, the fungus suspected in the current meningitis outbreak can spread in the air.
The risks from these products have long been known but are being amplified now by a national shortage of many drugs that has forced doctors to seek custom-made alternatives to the usual first-choice treatments.
"Because of the incredible number of drugs that are out of stock or back-ordered, compounding pharmacies are working with local hospitals, clinics and physicians to fill that gap," said David Miller, executive vice president of the International Academy of Compounding Pharmacists, a trade organization.
These products have had remarkable growth. More than 7,500 compounding pharmacies operate in the U.S., up from 5,000 in 2009, Miller said. They account for a $3 billion segment of the drug market and 3 percent of all prescriptions filled.
Some say this industry needs more regulation.
"There's not a lot of oversight of compounding pharmacies" compared with drug manufacturers, said Allen Vaida, executive vice president of the Institute for Safe Medication Practices, a suburban Philadelphia advocacy group that tracks medication errors.
Dr. William Schaffner, an infectious-disease specialist at Vanderbilt University, agreed.
"They fall into this gray area and no one supervises in a rigorous fashion their manufacturing processes. The state pharmacy boards don't have the resources or the knowledge or experience," and the FDA does not get involved unless a problem occurs, he said.
The FDA has said the steroid in the current meningitis outbreak came from the New England Compounding Center, based in Framingham, Mass. The company recalled three lots of the drug last week -- 17,676 vials -- and has said it has voluntarily suspended operations and is working with regulators to identify the source of the infection. Investigators also are looking into the antiseptic and anesthetic used during the injections
Deadly meningitis outbreak spreads
On Thursday, investigators urged doctors nationwide to avoid all products from the New England company. At least 23 states have received vials from the three recalled lots.
Meningitis outbreak linked to Mass. pharmacy
The company has been warned about its compounding products before, reports the CBS News Investigative Team.
There were two complaints filed against the company -- in 2002 and 2003 -- that were investigated and as a result the company entered into an agreement in 2006 with the Massachusetts Department of Health to correct any deficiencies. That same year, the FDA warned the company along with four other firms against compounding topical anesthetic creams for "general distribution rather than responding to the unique medical needs of individual patients."
Too much anesthetic in a rubbed-on cream can cause seizures and irregular heartbeats, and at least two deaths have resulted, the FDA said.
In March 2012, a complaint unrelated to the meningitis case was filed against the company regarding the potency of its eye medication. That complaint is still open and pending, according to the investigative team.
Compounding pharmacies are meant to supply products to meet unique patient needs, and to prepare drug products that are not available commercially, based on an individual prescription. They may cross a line if they supply a product on a large scale to a clinic or hospital without individual prescriptions, Miller and other experts said.
"They, in effect, since they do this on a large scale, have become mini-pharmaceutical companies," Schaffner said.
Miller, of the pharmacy trade group, said that in the current outbreak, it appears that the New England company was dispensing drugs widely to clinics and hospitals instead of filling individual prescriptions.
Some compounding pharmacies have had more than one troubling episode. And some products seem to have problems over and over again.
In May, officials reported 33 cases in seven states of a fungal eye infection stemming from products mixed in a Florida pharmacy that also prepared supplements that killed 21 elite polo horses in 2009.
The same steroid in the current outbreak was also tied to five cases of a different type of fungal infection in North Carolina in September 2002. Those patients also had shots from pain clinics, and one died.
Popular in Health
- "Goo" from naked mole rat may protect against cancer
- CDC: HPV vaccine reduced disease rates in teen girls 56%
- Parkinson's disease groups offended by Kanye West lyric
- Natura Pet Products recalls dry foods over salmonella
- Skin cancer self-exam: What to look for (PHOTOS)
- Obesity's "disease" risk no secret despite new classification
- Limit food stamps for sodas, 18 mayors ask government
- Japanese "eyeball licking" trend carries blindness risk